Dr. Alexandre Furman, MD
What this data tells you about Dr. Furman
Dr. Alexandre Furman is a pulmonary disease in Tampa, FL, with 17 years in practice. Based on federal Medicare data, Dr. Furman performed 7,850 Medicare services across 2,566 unique beneficiaries.
Between the years covered by Open Payments, Dr. Furman received a total of $13,357 from 19 pharmaceutical and/or device companies across 72 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Furman is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Hospital follow-up visit, high complexity | 2,506 | $94 | $199 |
| Hospital follow-up visit, moderate complexity | 1,129 | $62 | $139 |
| Office visit, established patient, complex (40-54 min) | 713 | $132 | $328 |
| Remote patient monitoring management, 20 min/month | 525 | $37 | $95 |
| Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | 516 | $30 | $78 |
| Remote patient monitoring device, 30 days | 400 | $37 | $102 |
| Initial hospital admission, high complexity | 374 | $136 | $383 |
| Office visit, established patient (30-39 min) | 331 | $94 | $295 |
| Nursing facility visit, moderate complexity | 270 | $83 | $175 |
| Critical care, first 30-74 min | 207 | $170 | $545 |
| Nursing facility visit, low complexity | 127 | $58 | $133 |
| Test for exercise-induced lung stress | 118 | $26 | $65 |
| Test to determine lung volumes using gas dilution or washout | 118 | $32 | $83 |
| Test to examine how well the lungs exchange gases | 117 | $42 | $110 |
| New patient office visit, complex (60-74 min) | 89 | $160 | $370 |
| Test to measure expiratory airflow and volume changes before and after medication administration | 71 | $29 | $74 |
| Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | 61 | $14 | $36 |
| Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | 51 | $143 | $320 |
| New patient office visit (45-59 min) | 37 | $122 | $398 |
| Office visit, established patient (20-29 min) | 36 | $71 | $215 |
| Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes | 19 | $105 | $248 |
| Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 10 minutes | 13 | $31 | $84 |
| Sleep study including heart rate, breathing, airflow, and effort | 11 | $71 | $405 |
| New patient office visit (30-44 min) | 11 | $88 | $259 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
The majority of payments (72%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in pulmonary disease and does not inherently indicate bias, but patients may wish to be aware.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Furman is a clinical cardiology specialist, with above-average Medicare volume (top 2% in FL), and high industry engagement (speaking/promotional, top 16%), with 17 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Furman experienced with hospital follow-up visit, high complexity?
Does Dr. Furman receive payments from pharmaceutical companies?
How do Dr. Furman's costs compare to other pulmonary diseases in Tampa?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology